Canopy Growth Corporation

$1.03 ▼ -0.96%
2026-06-06 07:10:00

Explore Canopy Growth Corporation stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.

Market Cap
$469 M
Current Price
$1.03
52W High / Low
$3.28 / $1.18
Stock P/E
Book Value
$1.91
Dividend Yield
ROCE
-8.06%
ROE
-52.88%
Face Value
EPS
$-1.33
Exp Qtr EPS
Sector
Healthcare

CGC — Monthly Price History

Adjusted close price  ·  Hover to see price & month

Pros

  • Short-term liquidity looks comfortable.
  • Valuation is not stretched on P/E basis.

Cons

  • Return on equity is on the weaker side.
  • Capital efficiency is modest.
  • Operating margin is thin.
  • Net margin is relatively low.

Sift Stocks

S.No. Name Price P.E. Market Cap Div Yld % ROCE ROE 52Week High/ Low Book Value
1. Zoetis Inc. $79.44 12.31 $32.53 B 1.64% 27.18% 62.41% $171.52 / $72.38 $7.84
2. United Therapeutics Corporation $549.87 18.12 $23.32 B 20.73% 19.24% $609.35 / $272.12 $162.6
3. Viatris Inc. $15.88 $18.12 B 3.09% 0.84% -1.97% $17.53 / $8.44 $12.78
4. Neurocrine Biosciences, Inc. $163.88 24.8 $16.58 B 16.37% 21.64% $169.57 / $122.14 $32.5
5. Elanco Animal Health Incorporated $23.63 $11.8 B 2.14% -3.64% $27.72 / $13.16 $13.17
6. Dr. Reddy's Laboratories Limited $13.24 25.19 $11.1 B 0.01% 4.24% $14.49 / $12.06 $4.23
7. Alkermes plc $42.8 47.15 $7.2 B 13.07% 8.82% $44.57 / $25.17 $10.99

Quarterly Results

Figures shown in M / B

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Sales74.54 M66.68 M72.13 M65.03 M74.76 M
Operating Profit-13.1 M-14.67 M-17.86 M-4.39 M-19.5 M
Net Profit-62.63 M-1.64 M-41.53 M-220.79 M-121.9 M
EPS in Rs-0.15-0-0.1-0.52-0.29-1.48

Profit & Loss

Figures shown in M / B

2025202420232022
Sales269 M297.15 M333.25 M475.7 M
Operating Profit-66.39 M-127.96 M-395.78 M-638.49 M
Net Profit-598.12 M-657.27 M-3.28 B-310.04 M
EPS in Rs-1.41-1.55-7.75-0.73

Balance Sheet

Figures shown in M / B

2025202420232022
Total Assets917.7 M1.3 B2.44 B5.61 B
Total Liabilities430.49 M799.82 M1.68 B1.98 B
Equity487.21 M500.37 M758.43 M3.58 B
Current Assets294.57 M371.18 M1.08 B1.73 B
Current Liabilities94.4 M234.72 M803.84 M213.19 M

Cash Flow

Last available yearly cash flow history

2025202420232022
Operating CF-165.75 M-281.95 M-557.55 M-545.81 M
Investing CF-47.79 M241.59 M433.38 M230.82 M
Financing CF148.66 M-465.06 M-19.69 M-45.53 M
Free CF-177.03 M-285.95 M-568 M-593.92 M
Capex-11.28 M-4 M-10.45 M-48.11 M

5Y Margin & Growth History

Last 5 years of annual financial statement data.

2025202420232022
Revenue Growth %-9.47%-10.83%-29.94%
Earnings Growth %9%79.95%-957.32%
Profit Margin %-222.35%-221.19%-983.68%-65.18%
Operating Margin %-24.68%-43.06%-118.76%-134.22%
Gross Margin %29.56%27.22%-19.06%-39.4%
EBITDA Margin %-178.19%-105.28%-864.2%-11.14%

Dividend & Split History

Latest dividend payments and stock split events.

Dividend History

No dividend history available.

Stock Splits

DateSplit
2023-12-201:0.1

Shareholding Pattern

Shares and value shown in M / B

Holder Name Type Shares Value % Out Report Date
AdvisorShares Trust-AdvisorShares Pure Cannabis ETF Mutual Fund 0.3 M $0.3 M 0% 2026-02-28
SPDR INDEX SHARES Fd.S-State Street SPDR S&P Intl Small Cap ETF Mutual Fund 0.13 M $0.13 M 0% 2026-01-31
SPDR INDEX SHARES Fd.S-State Street SPDR PORT. Developed World ex-US E Mutual Fund 0.02 M $0.02 M 2026-01-31
Jane Street Group, LLC Institutional 7.43 M $7.43 M 0.02% 2025-12-31
Tidal Investments LLC Institutional 6.75 M $6.75 M 0.02% 2025-12-31
Amplify ETF Trust-Amplify Alternative Harvest ETF Mutual Fund 6.75 M $6.75 M 0.02% 2025-12-31
Susquehanna International Group, LLP Institutional 5.14 M $5.14 M 0.01% 2025-12-31
Caitong International Asset Management Co., Ltd Institutional 4.6 M $4.6 M 0.01% 2025-12-31
Shaw D.E. & Co., Inc. Institutional 4.23 M $4.23 M 0.01% 2025-12-31
Morgan Stanley Institutional 2.06 M $2.06 M 0% 2025-12-31
Citadel Advisors Llc Institutional 2.03 M $2.03 M 0% 2025-12-31
Headlands Technologies LLC Institutional 0.99 M $0.99 M 0% 2025-12-31
Barclays Plc Institutional 0.9 M $0.9 M 0% 2025-12-31
Goldman Sachs Group Inc Institutional 0.78 M $0.78 M 0% 2025-12-31
Northern Lights Fund Trust IV-USA Mutuals Vice Fund Mutual Fund 0.1 M $0.1 M 0% 2025-12-31

Frequently Asked Questions — Canopy Growth Corporation

Will Canopy Growth Corporation stock hit $1 in 2026?

Canopy Growth Corporation (CGC) is currently trading at $1.03, with a 52-week range of $1.18 to $3.28. Reaching the $1 level would represent a 20% gain from the current price — a target many investors consider when evaluating near-term upside potential.

Wall Street analysts currently have a consensus price target of $1.79 for Canopy Growth Corporation, with a None rating, and the most bullish analysts see the stock reaching as high as $1.79. Whether Canopy Growth Corporation can reach $1 in 2026 depends on several factors: revenue and earnings growth trajectory, broader market conditions, sector sentiment within the Healthcare space, and any company-specific catalysts such as product launches, earnings beats, or strategic announcements.

Historically, CGC has delivered a -66.7% CAGR over the past 5 years, which suggests the stock has demonstrated meaningful long-term growth momentum. However, past performance does not guarantee future results, and short-term price movements can be influenced by macroeconomic shifts, interest rate changes, and investor sentiment. Use the CGC Stock Return Calculator on StockSifting to model different growth scenarios and see how various CAGR assumptions translate to potential price targets. This content is for informational purposes only and does not constitute financial advice.

Is Canopy Growth Corporation stock worth buying at $1.03?

Whether Canopy Growth Corporation (CGC) is worth buying at $1.03 depends on your investment goals, time horizon, and risk tolerance. Here is a breakdown of the key metrics investors typically evaluate:

Valuation: Valuation data is currently limited — check the full ratios section on StockSifting for the latest P/E, P/B, and EV/EBITDA figures.

Profitability & efficiency: Canopy Growth Corporation has a Return on Capital Employed (ROCE) of -8.1%, which reflects modest capital efficiency. Its Return on Equity (ROE) stands at -52.9%.

Financial health: The Debt-to-Equity ratio of 33.65 indicates a higher degree of financial leverage — investors should monitor debt servicing capacity.

Analyst view: The Wall Street consensus recommendation for CGC is currently None, with a mean price target of $1.79 based on 1 analyst ratings. Always conduct your own due diligence and consider consulting a qualified financial advisor before making any investment decisions. Nothing on StockSifting constitutes financial advice.

What is the analyst price target for Canopy Growth Corporation (CGC) in 2026?

As of 2026, Wall Street analysts have set a consensus (mean) price target of $1.79 for Canopy Growth Corporation (CGC), aggregated from 1 analyst ratings. The overall analyst recommendation is None.

The price target range spans from $1.79 on the bearish end to $1.79 on the most optimistic projection, with a median target of $1.79. This wide range reflects differing views on Canopy Growth Corporation's growth prospects, competitive positioning, and macroeconomic sensitivity.

It is important to note that analyst price targets are forward-looking estimates based on financial models, earnings projections, and sector assumptions — they are not guarantees. Targets are regularly revised following quarterly earnings results, management guidance updates, or shifts in the broader economic outlook. Stocks can trade significantly above or below analyst targets depending on market conditions. View the full analyst breakdown and track target revisions on the CGC analysis page on StockSifting.

What will Canopy Growth Corporation stock be worth in 2029?

Projecting Canopy Growth Corporation (CGC)'s stock price 3 years into the future — to 2029 — requires making assumptions about the company's earnings growth, valuation multiple, and broader market conditions. No projection is guaranteed, but historical growth rates offer a reasonable starting point.

Based on CGC's historical 5-year Compound Annual Growth Rate (CAGR) of -66.7%, if that rate of growth were to continue, the stock could reach approximately $0 by 2029 — up from its current price of $1.03. This projection assumes the historical CAGR holds, which depends on Canopy Growth Corporation sustaining its revenue growth, maintaining profit margins, and the market continuing to reward it at a similar valuation multiple.

In reality, stock prices rarely follow a straight-line trajectory. Short-term volatility, earnings misses, sector rotations, interest rate changes, and macroeconomic events can all cause significant deviations from any modeled path. Investors with a 3-year horizon should focus on the fundamental business trajectory — revenue growth, expanding margins, and free cash flow generation — rather than short-term price fluctuations.

You can model different scenarios — conservative, base, and bull case — using the CGC Return Calculator on StockSifting. Enter any investment amount and CAGR assumption to see projected outcomes over your chosen time horizon. All projections are mathematical estimates only and do not constitute financial advice.